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Abstract 
Leukocyte-specific protein 1 (LSP1) is an F-actin- and Ca
2+
-binding, 
intracellular cytoskeletal and nuclear phosphoprotein expressed in hematopoietic lineage 
and endothelial cells. It has been shown to play an important role in leukocyte motility 
and recruitment during inflammation when leukocytes interact with matrix proteins or the 
endothelial cells of postcapillary venules at the site of infection or injury. The role of 
LSP1 in microvascular hyperpermeability during neutrophil recruitment is the focus of 
this study. To induce neutrophil recruitment in the cremasteric microvasculature, mouse 
cremaster muscle was treated by superfusion with CXC chemokine KC 
(Keratinocyte-derived chemokine, CXCL1), MIP-2 (Macrophage inflammatory protein-2, 
CXCL2) or intrascrotal injection with the cytokine tumor necrosis factor- (TNF). 
Neutrophil recruitment was visualized and determined by intravital microscopy that 
measures neutrophil adhesion and emigration. The changes of microvascular permeability 
after chemokines or cytokine are simultaneously measured by the use of fluorescent 
intravital microscopy. I observed that both KC and TNF induced similar increases in 
microvascular permeability in wild-type and LSP1-deficient mice. The emigration of 
neutrophils was significantly lower in response to KC and TNF in LSP1-deficient mice 
than in wild-type mice. However, the permeability increases induced by each emigrated 
neutrophil in LSP1-deficient mice were significantly higher compared with that in 
wild-type mice. When the circulating neutrophils were depleted by >98% by using 
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anti-neutrophil antibodies, neutrophil rolling, adhesion and emigration and microvascular 
hyperpermeability in response to KC and TNF were completely inhibited to the basal 
level in the inflamed venules. I conclude that neutrophil-endothelial cell interactions 
dictate the increases of microvascular permeability in inflamed tissues, and 
LSP1-deficient neutrophils contribute much more to the permeability increases than 
wild-type neutrophils do.  
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Introduction 
1. Inflammation  
Inflammation is an extremely important process for our body to respond to 
harmful stimuli or injuries, and it is a complex immune response which is under very 
well control. Inflammation can be divided into acute and chronic inflammation. Acute 
inflammation is the initial response that is characterized by the increased movement 
of leukocytes and vascular hyperpermeability at the postcapillary venules in the 
inflamed tissues. When there are harmful stimuli or injuries, resident cells in the 
tissue will begin to release inflammatory mediators. In the inflamed area, vascular 
permeability increases and fluid and proteins leak out of blood vessel. These exudates 
contain complement proteins and antibodies which can opsonize or kill harmful 
microbes [1]. Meanwhile, leukocytes in blood flow are activated, and they interact 
with vascular endothelium and emigrate along the chemoattractant gradient to the 
inflamed site. Acute inflammation is a short process which lasts hours to days, and the 
process stops once the stimuli are removed. If the stimuli cannot be removed in a 
short time, inflammation is prolonged and turns to chronic inflammation which is 
characterized by destruction, repairing and healing of tissue.  
Inflammation is sometimes regarded as a “double-edged sword”. In the 
healthy condition, every step in inflammation is under close regulation by our body, 
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but abnormalities during inflammation cause many human diseases. For example, 
allergy reaction is due to hypersensitive immune response to allergens. Dysfunctional 
leukocytes make patients vulnerable to infections (e.g., Chédiak–Higashi syndrome). 
Also chronic inflammation can cause many diseases such as atherosclerosis, 
rheumatoid arthritis, and even cancer. Inappropriate inflammatory reactions disrupt 
normal life of the person with inflammatory disorder. It is, therefore, important to 
study the mechanisms involved in regulating all aspects of inflammation. 
2. Leukocyte recruitment 
        The hallmark feature of acute inflammation is the recruitment of 
neutrophils to the inflamed site. There are several sequential steps in this cellular 
process in which neutrophils move from the blood and finally reach the inflamed site. 
The initial interaction between neutrophils and endothelial cells that is critical in 
leukocyte recruitment cascades is when the flowing leukocytes start tethering and 
rolling on the endothelium [2]. This first important step is mainly dependent on one 
family of cell adhesion molecules (CAMs) called selectins which have three members, 
E-selectin, P-selectin and L-selectin. These three selectins were named after the cells 
where they were first discovered. They have been reported to have overlapping and 
distinctive functions. E-selectin is responsible for dramatic decreases in rolling 
velocity alone, but still P- or L-selectin is indispensable for the initial capture of 
neutrophils for their E-selectin-dependent slow rolling [3]. However, upon some other 
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inflammatory stimuli, P-selectin is required for rolling flux increases and velocity 
reductions [4]. L-selectin is important in the tethering efficiency between slow-rolling 
neutrophils and endothelial cells, but has no role in rolling velocity [5]. Some other 
studies suggest that the rolling and tethering processes can rely on other molecules in 
addition to selectins. Human vascular adhesion protein-1 (VAP-1) can mediate 
tethering and rolling, and 4-integrin supports the rolling of certain subsets of 
leukocytes during recruitment [6-8].  
        Integrins, which are another family of CAMs, contain two chains,  and β 
subunits. There are eighteen  subunits and eight β subunits in mammals, which are 
associated in different combinations to generate 24 integrins. Several integrins in the 
β2, β7, and β1 subfamilies are expressed in leukocytes [9]. The rolling leukocytes are 
activated through the interactions with chemokines or other chemoattractants present 
on the luminal surface of endothelial cells to become firmly adherent to the 
endothelium. The transition from rolling to adherent is dependent on integrins. It has 
been reported that neutrophil adherence requires the activation of β2 integrin, and the 
two CD11/CD18 integrins, CD11a/CD18 (L2 integrin, also called LFA-1) and 
CD11b/CD18 (M2 integrin, also called Mac-1), are the first discovered adhesive 
molecules [10]. By the use of LFA-1- and Mac-1-deficient mice, it has been reported 
that both LFA-1 and Mac-1 are important in neutrophil adhesion, and it seems LFA-1 
plays a predominant role [11]. Henderson et al. reported that LFA-1 plays an 
important role in the initial adhesion, and Mac-1 supports the longer-lasting adhesion 
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[8]. Mac-1 seems more important during the transition between adhesion and 
transmigration. The 4-integrin, which can act like selectin to support rolling and 
tethering, also can perform the function of β2-integrin to mediate adhesion [8, 12]. 
       A new step in leukocyte recruitment, called intraluminal crawling, was 
identified by Alan R Schenkel and his colleagues. They found that monocytes moved 
after firm adhesion to an endothelial junction to transmigrate, and that LFA-1 and 
Mac-1 both had a role in this movement [13]. Blockade of Intercellular adhesion 
molecule (ICAM)-1 or ICAM-2 prevented monocytes from moving to the junction 
[13]. Neutrophils in postcapillary venules also crawl to endothelial junctions to 
migration after adhesion. Phillipson et al. discovered that LFA-1-deficient neutrophils 
had problems in adhesion, but still could move properly in the venule. 
Mac-1-deficient neutrophils showed significantly decreased intraluminal crawling 
compared with wild-type neutrophils. The inhibition of ICAM-1 affected crawling, 
but blockade of ICAM-2 did not affect crawling [14]. The authors suggested that the 
LFA-1-dependent adhesion and Mac-1-dependent crawling are both important for the 
next recruitment step, neutrophil emigration [14]. 
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Figure 1. Leukocyte recruitment cascade. During inflammation, leukocytes in blood 
vessels tether and roll along the vessel lumen, and then adhere to endothelial cells. After 
firm adhesion, leukocytes crawl to optimal sites and begin to transmigrate. 
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        After crawling to the optimal site, leukocytes immediately start migrating 
across the endothelium. Compared with other steps in leukocyte recruitment, 
leukocyte transendothelial migration is the least studied step. Many adhesion 
molecules are involved in this process, including ICAM-1, ICAM-2, junctional 
adhesion molecule (JAM)-A, JAM-C, platelet endothelial cell adhesion molecule-1 
(PECAM-1) and CD99 [15]. There are two routes by which leukocytes emigrate 
across the endothelium, paracellular or transcellular. An in vivo study demonstrated 
that neutrophils prefer to migrate through endothelial cells predominantly rather than 
emigrate via endothelial junctions from venules in response to FMLP [16]. Yang et al. 
reported that a large number of neutrophils transmigrate via the transcellular route 
after 24-h treatment with TNF, while after 4-h TNF treatment, neutrophils still 
prefer the paracellular route [17]. They also found that lymphocytes transmigrating 
through paracellular or transcellular route are comparable [17]. It seems that the 
pattern of transmigration depends on the cell type, inflammatory stimuli and the time 
of assessment.  
The leukocyte recruitment cascade, selectin-dependent rolling followed by 
integrin-dependent adhesion and a complex transmigration through the endothelium, 
is a generally accepted leukocyte recruitment paradigm that has been demonstrated in 
cremaster muscle, mesentery and many other tissues. But in some other organs the 
cascade may not be exactly the same [18]. In the liver, there are neither rolling 
leukocytes nor selectin expression within the sinusoids [19]. Adhesion is not 
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dependent on the rolling and tethering and still exists when β2- or 4-integrins are 
blocked. In the brain, platelets, which express P-selectin, play an important role in 
leukocyte recruitment. An endothelium-platelet–leukocyte bridge is formed during 
recruitment cascade [18]. A better understanding of the organ-specific mechanisms of 
leukocyte recruitment is important for the development of novel therapeutics for 
various inflammatory disorders.   
2.1 Chemokines in leukocyte recruitment 
     Chemokines are a largest family of cytokines, the name of which comes 
from two words: chemotactic cytokines. Chemokines are involved in many processes 
in inflammation and immunity. They are small proteins that signal through binding to 
their G protein-coupled receptors (GPCRs) on target cells [20]. During inflammation, 
chemokines are generated by many types of cells, such as emigrated leukocytes, 
resident macrophages, and tissue cells including endothelial cells, epithelial cells, 
and fibroblasts. There are four subfamilies of chemokines CXC, CC, CX3C and C 
chemokines named according to the position of the first two conserved cysteine 
residues [21]. As mentioned earlier, integrins play a very important role in leukocyte 
adhesion. Integrins mediate adhesion through binding to their ligands on endothelial 
cells or in interstitial tissues. Chemokines increase the adhesion of leukocytes by 
inducing rapid and transient high affinity binding of integrins to their ligands. For 
example, CXC and CC chemokines induce a change LFA-1 from a low affinity to a 
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high affinity state in a few seconds (rapid), after while LFA-1 returns to a low 
affinity state in minutes (transient) [22]. The affinity of 4-integrin is rapidly and 
transiently increased in monocytes stimulated with formyl peptide (FP) or stromal 
cell-derived factor-1 (SDF-1, CXCL12) [23]. Chemokines induce changes not 
only in the affinity of integrins but also in the motility. After a cell is treated with a 
CXC chemokine, its LFA-1 is redistributed and clustered together in seconds [22]. 
However, chemokine-induced binding of integrins to their ligands varies in different 
cell types. SDF-1 rapidly increases integrin binding to ICAM-1 and not to vascular 
cell adhesion molecule-1 (VCAM-1) in lymphocytes. But in monocytes, SDF-1 
also induces significant increases in VCAM-1 binding [22, 23].  
2.2 Leukocyte transendothelial migration 
            There are two routes for endothelial transmigration and many adhesion 
molecules are involved in the process [15]. In this chapter, I will introduce what and 
how these molecules are involved.  
2.2.1 ICAM-1 
         Intercellular adhesion molecule (ICAM)-1 is a transmembrane protein 
and belongs to the immunoglobulin (Ig) superfamily. ICAM-1 is constitutively 
expressed in endothelial cells at a low concentration, but its expression can be 
significantly upregulated after cytokine stimulation [24]. An in vitro study showed 
that blockade of ICAM-1 expression by antibody inhibited neutrophil transmigration 
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[25]. Yang et al. reported that high levels of ICAM-1 in endothelial cells enhanced 
both trans- and para-cellular transmigration of neutrophils, but did not have a role in 
T-lymphocyte transmigration [17]. During transmigration, ICAM-1 tends to 
relocalize and is enriched in the endothelial border, where these molecules form a 
cup-like structure that surrounds the site of transmigration [26, 27]. This 
ICAM-1-rich projection accompanies the whole process of transmigration, and 
inhibition of this structure decreased neutrophil transmigration [27]. ICAM-1 
engagement activates endothelial Pyk2 and Src, which are endothelial signaling 
molecules that are important in neutrophil transmigration [28].  
2.2.2 JAMs 
Junction adhesion molecule (JAM) is an immunoglobulin gene 
superfamily member and is expressed and concentrated in intercellular junctions of 
endothelial and epithelial cells [29]. JAM-A is also expressed in circulating cells, 
such as neutrophils, monocytes and platelets [30]. JAM-A is a ligand of LFA-1 and 
also contributes to LFA-1-dependent transmigration of neutrophil [31]. In 
JAM-A-deficient mice, neutrophil transmigration induced by LTB4 or 
platelet-activating factor (PAF) is comparable with that in WT mice, but in response 
to tumor necrosis factor (TNF)- and interleukin (IL)-1β, inhibition or deficiency of 
JAM-A significantly decreases neutrophil transmigration [32, 33]. Like JAM-A, 
JAM-C is also expressed in monocytes and platelets of human, but it is not expressed 
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in mouse leukocytes [30]. Blockade of JAM-C by antibodies in vitro or in vivo both 
significantly decreased neutrophil transendothelial migration [34], and 
overexpression of JAM-C in mice enhanced neutrophil transmigration [35]. It seems 
JAM-C is one molecule that is involved in this process. Another research group 
reported that functional blockade of JAM-C had no effect on neutrophil 
transmigration under shear flow, but JAM-C did contribute to the formation of a 
small gap at sites where neutrophils transmigrate [36].  
2.2.3 PECAM-1 
          Platelet endothelial cell adhesion molecule-1 (PECAM-1), also called 
CD31, is a member of the Ig superfamily. It is expressed on the surface of circulating 
cells and is rich in endothelial cell intercellular junctions [37]. A polyclonal antibody 
against PECAM-1 inhibited neutrophil transmigration by about 20%; interactions 
between leukocyte and endothelial PECAM-1 are crucial in this process [38]. By the 
use of PECAM-1-deficient mice, PECAM-1 was found to be involved in neutrophil 
transmigration induced by IL-1β, but not TNF [39]. Endothelial PECAM-1 can 
relocalize to the cellular borders to form a “passive ligand” for neutrophil PECAM-1 
for their interactions during the transmigration [40] .  
2.2.4 CD99 
CD99 is a small membrane glycoprotein with unique properties, and it 
has no homology with any other protein family. Mouse CD99 is expressed in both 
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endothelial cells and leukocytes [41]. Blockade of CD99 by antibody significantly 
decreases neutrophil transmigration, and blockade of CD99 in either endothelial cells 
or neutrophils inhibits neutrophil transmigration. Similar to PECAM-1, the 
homophilic CD99 interactions between endothelial cells and neutrophils is critical 
for this process [42]. Unlike PECAM-1, the role of CD99 is not dependent on the 
type of stimulus (both IL-1β and TNF) [42]. The reduction of transmigration in 
vitro is due to trapping of neutrophils between endothelial junctions and their 
inability to complete the transmigration process [43]. CD99L2 is a novel protein 
related to CD99, and similar to CD99, it is also involved in neutrophil transmigration 
[43]. 
2.2.5 VE-cadherin 
VE-cadherin is rich in inter-endothelial cell contacts and is important in 
maintaining the integrity of endothelial cells [44]. Unlike other molecules, 
VE-cadherin is a negative regulator of neutrophil transmigration. It has been shown 
that using a monoclonal antibody against mouse VE-cadherin increased the number 
of transmigrated neutrophils by more than three times compared to that in the control 
mice [44]. During transmigration, there is a transient gap formation between 
VE-cadherins which reseals in 5 min after transmigration [45].  
3. Neutrophils in inflammation 
     In humans, neutrophils constitute the majority of leukocytes in the blood 
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(60%-70%), and also the majority of granulocytes (95%). Neutrophils are produced 
in bone marrow and have a short half-life (8-10 h). In healthy people, neutrophils are 
found in the circulation in a resting state. During inflammation, neutrophils are 
activated and induced to degranulate. There are four types of neutrophil granules [46], 
including primary (azurophil or peroxidase-positive) and secondary (specific or 
peroxidase-negative) granules. Gelatinase (tertiary) granules are gelatinase-rich 
peroxidase-negative granules. Finally, secretory vesicles have unique properties 
which make them different from the other three granules [47]. Signaling through 
selectin binding to its ligand can mediate the mobilization of secretory vesicles, 
which can induce neutrophils to present β2-integrins on its surface, and further 
enhance neutrophil adhesion. The gelatinase granules can support neutrophil 
emigration because gelatinase disrupts the vascular basement membrane. Azurophilic 
granules, which contain myeloperoxidase (MPO), elastase and other bactericidal 
mediators, have important role in neutrophil phagocytosis [48].  
        Upon activation, neutrophils secrete many inflammatory mediators, 
including leukotrienes, prostaglandins, cytokines and chemokines. In response to 
different inflammatory stimuli, neutrophils secrete proinflammatory cytokines, such 
as TNF- and IL-1β [49]. Neutrophils are also a source of chemokines. IL-8 
(CXCL8) is the first chemokine proved to be synthesized by neutrophils [50]. To 
date many chemokines have been demonstrated to be synthesized by neutrophils. 
Activated neutrophils are reported to produce leukotrienes and prostaglandins, which 
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are derived from arachidonic acid [51]. At the site of inflammation, leukotrienes and 
prostaglandins have effects on vasodilation, and permeability increases in 
postcapillary venules. Leukotrienes have been reported to have the ability to increase 
neutrophil chemotaxis and adhesion through integrins [52]. With the activation of 
neutrophils, NADPH oxidase is also activated to produce reactive oxygen species 
(ROS), which are critical for the destruction and killing of bacteria [53].   
4. Vascular permeability 
4.1 Normal permeability 
The endothelium is a thin cellular monolayer on the interior surface of a 
blood vessel; it regulates the exchange of protein, water and even the movement of 
whole cells [54]. Vascular permeability is the sum of mechanisms that control the 
stability of barrier function and signal pathway. Transcellular permeability 
(transcytosis) and paracellular permeability are two routes for these molecular 
exchanges.  
4.1.1 Paracellular permeability 
To maintain the normal paracellular permeability, the inter-endothelial 
junctions present in endothelium, composed of adherens, tight and gap junctions, 
play an important role. Adherens junctions (AJs) and tight junctions (TJs) control 
endothelial cell-to-cell adhesion, whereas gap junctions are responsible for the 
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delivery of water, iron or other molecules from one cell to another [55]. Also, many 
proteins are located in the inter-endothelial junctions, such as JAM, claudins and 
PECAM-1, many of which are involved in the formation of junctions and the control 
of endothelial permeability [56].  
(1) Adherens junctions (AJs): 
VE-cadherin is the major component of AJs. It is a transmembrane adhesion 
protein specifically expressed at the endothelial cellular borders. VE-cadherin is 
responsible for homophilic adhesion of adjacent endothelial cells and further 
mediates permeability changes. Vascular permeability significantly increases after 
the blockade of VE-cadherin by a monoclonal antibody [57]. The extracellular 
domain of VE-cadherin is 5 cadherin-like repeats which bind to the homophilic 
VE-cadherin on the adjacent cell, whereas the intracellular domain binds to the 
intracellular linker proteins -catenin, β-catenin, and plakoglobin. The 
catenin-cadherin complex links AJs to the actin cytoskeleton [58, 59]. But one 
research group reported that -catenin cannot bind to β-catenin-cadherin complexes 
and the actin cytoskeleton simultaneously [60]. One actin-binding protein called 
EPLIN is demonstrated to fill this gap and it can link the catenin-cadherin complex 
and the actin cytoskeleton at the same time [61]. p120 catenin is also important in AJ 
integrity. The juxtamembrane domain of VE-cadherin binds directly to p120, which 
is reported to promote cadherin clustering and increase adhesion [62]. Furthermore, 
p120 controls the expression level of VE-cadherin. Inhibition of p120 dramatically 
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decreases the cellular level of VE-cadherin [62]. 
(2) Tight junctions (TJs): 
        TJs only constitute about 20% of total junctions in endothelial cells, but 
still have important roles in maintaining normal permeability. TJs are formed by 
claudins, occludin and JAMs [63]. Occludin is the first-identified transmembrane 
protein in TJs [64]. Occludin is associated with zona occludens (ZO)-1 and ZO-2 is 
also bound to occludin through ZO-1. This bound is the linkage of actin cytoskeleton 
and occluding [65]. Different domains of occludin have effects on the regulation of 
paracellular permeability [66]. Like occludin, claudin is a transmembrane protein 
containing four transmembrane domains. Claudin also binds ZO-1 and then linked to 
the actin cytoskeleton [63]. Claudin forms homotypic adhesive plaques to improve 
cell-cell adhesion [67]. JAMs present in endothelial cells are up-regulated during 
inflammation. JAM-A, a member of the JAMs family, colocalizes with ZO-1 and 
A-6 in the TJs, which directly links JAM-A to F-actin [68]. JAMs have also been 
reported to play a role in neutrophil transendothelial migration; JAMs redistribute in 
this process. 
4.1.2 Transcellular permeability 
        Transcellular permeability is regulated by transcytosis, which mainly 
depends on the function of caveolae in endothelial cells. Caveolae can transport 
macromolecules from inside the blood vessel to the outside. Caveolae are abundant 
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in endothelial cells and accounts for about 20% of endothelial cell volume. 
Caveolin-1 is the protein that is responsible for caveolae assembly [69]. Caveolin-1 
has a domain rich in cholesterol, and the expression of caveolin-1 is dependent on 
cellular cholesterol level [70]. By using caveolin-1-knockout mice, a research group 
found that the microvascular permeability is significantly increased in these mice. 
When the expression of caveolin-1 is inhibited by siRNA, the lung vascular 
permeability dramatically increased [71, 72]. In caveolin-1-knock-out mice, the tight 
junctions in endothelial cells are much smaller than those in wild-type mice [72]. 
Caveolin-1 is a very important regulator of vascular permeability. It seems that there 
is a cross-talk between paracellular permeability and transcellular permeability 
through caveolin-1.  
4.1.3 Actin cytoskeleton: 
   The actin cytoskeleton, a dynamic subcellular structure, is a critical 
component in endothelial cell permeability [73]. The actin cytoskeleton is linked to 
the junctional proteins, such as cadherin in AJs and ZO in TJs [73]. In response to 
proinflammatory stimuli, inter-endothelial junctions fall apart and form a gap. It has 
been shown that inter-endothelial gap formation needs the contraction of endothelial 
cells, which is mediated by the actin cytoskeleton. Gap formation and actin 
reorganization require myosin light chain (MLC) phosphorylation,  which is 
regulated by MLC kinases [74].  Many inflammatory mediators have been reported 
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to increase vascular permeability via endothelial cell contraction or actin 
organization to form gaps between endothelial cells [75]. Some mediators, such as 
histamine, thrombin or bradykinin, are known to signal through GPCRs. The 
activation of GPCRs causes an intracellular Ca
2+ 
increase which can cause MLC 
kinase activation and myosin phosphorylation [76]. Tyrosine kinases are important 
for the effect of some other mediators on vascular permeability increases, and VEGF 
is one of these mediators. VEGF-induced permeability increases have been reported 
to play a role in tumor development and ischemia/reperfusion injury [76].  
4.2 Regulation of vascular permeability 
     Many molecules and mechanisms are involved in the maintenance of the 
integrity of endothelial barrier functions and the regulation of vascular permeability.  
4.2.1 Rho GTPases: 
        Rho GTPases are a family of small signaling G proteins, which are able to 
switch between active and inactive forms. The activation of this protein is regulated 
by guanine nucleotide exchange factors (GEFs) and GTPase activating proteins 
(GAPs). Activated RhoGTPases induce the changes of activities of the downstream 
factors to mediate some effects [77]. Three members of the RhoGTPase family are 
well-studied, Rac1, RhoA and Cdc42, and are involved in permeability control [78]. 
The role of RhoGTPases in endothelial barrier function was studied by using toxin B 
to inactivate the protein. Administration of toxin B results in the loss of endothelial 
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barrier function, which is accompanied by the formation of gaps between endothelial 
cells and decreases in F-actin [79]. Inhibition of Rac1 by lethal toxin has similar 
effects, such that permeability is significantly increased. Specifically, adhesion of 
endothelial cells through VE-cadherin is reduced and the AJs are disrupted, causing 
the opening of inter-endothelial cell junctions and an increase in gap formation [80]. 
This evidence indicated that Rac1 is important in maintaining endothelial barrier 
integrity under resting condition. Besides its role in the resting condition, Rac1 was 
been demonstrated to reduce the increase of permeability caused by TNF-. 
Increased activation of Rac-1 blocks gap formation and endothelial barrier 
breakdown induced by TNF- [81]. Activation of Rac1 by a protein activator 
cytotoxic necrotizing factor 1 (CNF-1) increases F-actin levels in the endothelial 
cells to strengthen the endothelial barrier. Increased activation of Rac1 also reduces 
PAF-induced permeability increases [82]. Similar to Rac1, Cdc42 is also critical in 
endothelial permeability maintenance [82]. Cdc42 was shown to have the ability to 
regulate the association of -Catenin and VE-cadherin [83]. Besides the maintenance 
of endothelial barrier, Cdc42 seems to have a role in permeability restoration. After 
disassembly of AJs by thrombin, AJs can start reassembly and Cdc42 is activated 
during this process. The inhibition of Cdc42 delays the reassembly of AJs [84]. 
RhoA is a negative regulator of endothelial barrier. The inhibition of RhoA improves 
the cell-cell adhesion and enhanced endothelial function [85]. The RhoA is activated 
in response to thrombin or lysophosphatidic acid (LPA) and is involved in 
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reorganization of the cytoskeleton and increases of permeability [86, 87]. 
4.2.2 Cytosolic calcium: 
          Calcium is an important second messenger involved in many cellular 
functions. Increases in intracellular calcium levels can be induced by many 
inflammatory mediators and these cause significant increases in microvascular 
permeability. It has been found that inhibition of calcium levels in endothelial cells 
block 50% of thrombin-induced permeability increases [88]. Further studies showed 
that F-actin cytoskeleton in endothelial cells was increased and reorganized after the 
increases in intracellular calcium concentration, and this was regulated by 
Ins(1,4,5)P3 levels [89]. The activation of MLC kinase is dependent on calcium 
levels, which induce MLC phosphorylation [90]. Cytosolic calcium levels are also 
critical in vascular permeability control. 
5. Leukocyte-specific protein 1 (LSP1) 
          Leukocyte-specific protein 1 (LSP1) is a 52kDa intracellular Ca
2+
- and 
F-actin-binding protein [91]. LSP1 was first found in lymphocytes and named as 
lymphocyte-specific protein 1 [92]. However, more recent studies found that LSP1 is 
expressed in all mouse and human leukocytes, including neutrophils, macrophages 
and lymphocytes [93, 94]. Therefore, LSP1 was renamed as leukocyte-specific 
protein 1 [95]. Mouse LSP1 contains 330 amino acids whereas its human homologue 
LSP1 is 339 amino acids protein [96, 97]. Both human and mouse LSP1 are 
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phosphoproteins and their sequences are highly conserved and largely identical. 
Eighty-five percent of the C-terminal in human LSP1 is identical compared to that of 
mouse LSP1. The Ca
2+
-binding sites in the two proteins are not conserved. Human 
LSP1 has a highly conserved basic domain which contains most of the serine and 
threonine residues which might be the targets of protein kinases [96]. LSP1 in 
lymphocytes is located in the cytoplasmic face of the plasma membrane and also 
associates with the cytoskeleton [92, 97]. Further studies showed that LSP1 binds to 
F-actin through the highly conserved COOH-terminal domain in both humans and 
mice [98]. Zhang et al. found in 2000 that there are four F-actin binding sites in 
human LSP1 [99]. LSP1 has been identified as one of the major substrates for 
mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2) in 
human neutrophils [100].  
5.1 LSP1 in leukocyte transendothelial migration 
      To study the role of LSP1, Jongstra-Bilen et al. generated LSP1-deficient 
(Lsp1
/
) mice on a 129/SvJ (WT) background and also indicated that LSP1 
deficiency in mice had no effect on myeloid development [101]. First, they induced 
inflammation in the peritoneum and found that the total number of infiltrating 
leukocytes, macrophages and neutrophils was significantly increased in Lsp1
/ 
mice 
compared with that in WT mice. Also, the total number of neutrophils reached 
maximal levels at 8 h in Lsp1
/
 mice while WT mice took 24 h. Then the emigrated 
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neutrophils in the peritoneum were isolated and stimulated with FMLP. Chemotaxis 
of neutrophils from Lsp1
/
 mice was about two-fold higher than that of neutrophils 
from WT mice [101]. In another inflammatory model, LSP1 had a similar role. 
Significantly increased number of neutrophils moved into knee joints of Lsp1
/
 mice 
in response to zymosan, whereas chemotaxis of Lsp1
/ 
neutrophils on fibrinogen was 
increased [102]. This evidence demonstrated that LSP1 is a negative regulator of 
leukocyte transendothelial migration. This negative role of LSP1 was further proved 
in neutrophil actin dysfunction (NAD) patients where LSP1 is overexpressed [103]. 
But another research team in a vitro experiment showed that Lsp1
/
 neutrophils had 
significantly lower speed in chemotaxis in the KC gradient. During chemotaxis, WT 
neutrophils formed lamellipodia and protrusions which were rarely seen in Lsp1
/ 
neutrophils. Unlike chemotaxis, superoxide production induced by phorbol 
12-myristate 13-acetate (PMA) was significantly higher in Lsp1
/ 
neutrophils than in 
WT neutrophils [104]. Li et al. found that the role of LSP1 in locomotion was 
biphasic by using three types of monocyte-differentiated U937 cells, U937 cells with 
no LSP1, with normal LSP1 and with 4-fold LSP1 overexpression. The cells with no 
LSP1 or normal LSP1 remained round and had smooth surfaces, whereas 
overexpression of LSP1 in cells caused the formation of projection on the surface 
which contained F-actin. Compared with cells with normal LSP1, the other two types 
both showed impaired motility. So the level of LSP1 in cell is important in regulation 
of cell motility [105]. Another group used intravital microscopy which can visualize 
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leukocytes and their interactions with the endothelium in the postcapillary venule to 
study the role of LSP1. They found that Lsp1
/ 
mice had significantly lower number 
of emigrating leukocytes in cremasteric microvasculature in response to TNF, IL-1β 
or the chemokine KC [106]. Obviously, LSP1 has a very important role in leukocyte 
transendothelial migration.  
5.2 LSP1 in endothelial cells 
         Liu et al. have demonstrated that LSP1 is expressed in mouse and human 
endothelial cells [106]. Endothelial LSP1 is mainly in the nucleus and moved to the 
cytoplasm to carry out its function [106, 107]. They also reported that the chimeric 
mice with normal endothelial cells but Lsp1
/
 leukocytes emigrated as effectively as 
WT mice. The WT leukocytes had difficulty emigrating through Lsp1
/
 endothelial 
cells [106]. Endothelial cells had been reported to form a dome-like structure to help 
leukocyte transmigration [107]. It seems that endothelial LSP1 also has a role in 
leukocyte transendothelial migration. 
5.3 LSP1 in cytoskeleton remodeling 
      In the NAD patient, neutrophils are abnormal in motility and actin 
polymerization. Neutrophils in these patients cannot form pseudopods or F-actin-rich 
projections and these abnormalities are associated with significant increases in LSP1 
[108]. Regulation of the actin cytoskeleton seems to be one of the physiological 
functions of LSP1. The high level expression of LSP1 in cells induced formation of 
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hair-like projections whereas, at normal levels of LSP1, the cells remain round [109]. 
And the elevated LSP1 in cells was mainly because of the increase of LSP1 binding 
to actin [110]. Therefore, morphological changes of actin cytoskeleton induced by 
LSP1 are dependent on the amount of this protein binding to F-actin. It is well known 
that actin cytoskeleton organization is crucial in cell movement. After attaching on the 
substrate, the cells spread and started organizing actin to form filopodia and 
lamellipodia [111].  
5.4 LSP1 in endothelial permeability 
         It is clear that cytoskeleton remodeling is a critical component in 
endothelial cell permeability [73]. LSP1 is an F-actin binding protein that is involved 
in cytoskeletal remodeling. So LSP1 may play a role in regulation of endothelial 
permeability. In an in vivo study, Lsp1
/
 mice had significantly lower permeability 
than WT mice after treatment with histamine [106]. Very few studies are done on the 
role of LSP1 on vascular permeability changes [112]. Further studies are required to 
find out the mechanisms by which LSP1 mediates endothelial permeability changes. 
6. Leukocyte–endothelial cell interactions and vascular permeability  
6.1 Cell adhesion molecules (CAMs) 
        There are at least three families of CAMs involved in 
leukocyte-endothelial interactions, selectins, integrins and integrin ligands. As I have 
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introduced in previous sections, selectins and integrins have been demonstrated to 
participate in leukocyte rolling and adhesion. The major integrin ligands belong to the 
Ig superfamily and are expressed on endothelial cells [113]. The most important 
members in this family are ICAM-1 and ICAM-2, which act as ligands for 
2-integrins LFA-1 and Mac1. ICAM-1 is expressed in many types of cells including 
endothelial cells, and the levels of ICAM-1 expression can be increased by 
proinflammatory stimuli, such as TNF or LPS [114, 115]. ICAM-2 is mainly 
expressed on endothelial cells, and its expression is not increased in response to 
cytokines. During transmigration, ICAM-1 tends to cluster and form a cup-like 
structure that surrounds the site of transmigration [26, 27]. One study showed that this 
ICAM-1 engagement caused a permeability increase which was mediated by Src 
phosphorylation of caveolin-1 both in vivo and in vitro [116]. Also ICAM-1 was 
found to co-localize with F-actin in endothelial cells and to trigger the remodeling of 
the actin cytoskeleton by forming a ring-like structure [117]. In addition to ICAM-1 
and ICAM-2, some other adhesion molecules are also involved in 
leukocyte-endothelial cell interactions, such as VCAM-1 and PECAM-1 [118]. 
6.2 Leukocyte-endothelial cell interactions and microvascular 
permeability 
       The leukocyte-endothelial cell interaction is a crucial process in 
inflammation. It is necessary for the circulating leukocytes to transmigrate through 
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the endothelial cells to inflammatory sites. The transendothelial migration process 
causes cell shape changes and actin remodeling which also contribute to vascular 
permeability increases. To date, whether the interaction between leukocytes and 
endothelial cells directly causes the increase of microvascular permeability is still 
controversial. Some studies have shown that the leukocyte-endothelial cell interaction 
is a critical component that leads to vascular dysfunction. In the ischemia model, 
neutrophil adhesion was associated with an increase in vascular permeability. And 
prevention or depletion of neutrophils significantly prevented the permeability 
increases [119, 120]. But inhibition of neutrophil adhesion did not completely 
eliminate the vascular dysfunction [121]. It seems that this interaction between 
leukocytes and endothelial cells is an important factor but not the only factor in 
microvascular permeability increases. In the postcapillary venule, the ICAM-1 
ligation, which is required by the leukocyte-endothelial cell interaction, causes 
permeability increase. And leukocyte adhesion, not leukocyte rolling is involved in 
the TNF-mediated permeability increases [122]. During leukocyte transmigration, in 
endothelial cells, there is an elevation of cytosolic free calcium concentration which 
is required for transendothelial migration and causes increases in endothelial 
permeability [123, 124]. Neutrophil adhesion has been proved to trigger the 
disorganization of AJs and degradation of endothelial catenins which is a component 
of AJs [125, 126]. It is known that leukocytes adherent to endothelial cells are a major 
source of ROS, which is critical for the destruction and death of bacteria in 
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inflammation [127, 128]. ROS also can cause gap formation, shape change and actin 
reorganization of endothelial cells [128]. All of these changes contribute to 
microvascular permeability increases. 
        However, some studies found that leukocyte adhesion and emigration are 
uncoupled with vascular permeability. Blocking leukocyte adhesion had no effect on 
leakage of venules in response to histamine, wherein some leaky venules there were 
no adherent leukocytes [129]. Another group reported that sites of leukocyte adhesion 
and migration were not associated with vascular leakage [130]. In a wound model, 
both permeability and neutrophil recruitment increased over 24h, but permeability 
reached peak levels at 6 h, faster than neutrophils (18 h). Inhibition of neutrophil 
influx by 90% had no effect on vascular permeability at 24 h. These research data 
demonstrated that leukocyte adhesion and emigration are temporally and spatially 
uncoupled with the increases of vascular permeability. 
 
 
 
 
 
 
 
27 
 
Hypothesis 
Leukocyte-specific protein 1 (LSP1) is an F-actin- and Ca
2+
-binding, 
intracellular cytoskeletal phosphoprotein expressed in hematopoietic lineage and 
endothelial cells. It has been shown to play an important role in neutrophil motility and 
recruitment during inflammation when neutrophils interact with the endothelial cells of 
postcapillary venules at the site of infection or injury. Some studies have shown that the 
interactions between leukocytes and endothelial cells could couple with microvasculature 
permeability increases. My hypothesis is that LSP1 is important in microvascular 
hyperpermeability during neutrophil recruitment in microvasculature in vivo. 
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Objectives 
 To identify the role of LSP1 in microvascular permeability increases induced by 
different inflammatory stimuli.  
 To identify the role of leukocyte-endothelial cell interactions in microvascular 
permeability increases induced by different inflammatory stimuli. 
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Materials and methods 
1. Animals 
Three types of mice were used in this study: C57BL/6, 129/SvJ and 
LSP1-deficient (Lsp1
/
) mice (Background mice are 129/SvJ mice). All animal 
protocols were approved by the University Committee on Animal Care and Supply 
(UCACS) at the University of Saskatchewan and met the standards of the Canadian 
Association of Animal Care. 
2. Intravital microscopy 
Intravital microscopy is a very powerful tool to visualize movement of cells. 
An upright microscope (model BX61WI, Olympus) was connected with a 3CCD 
color video camera (DXC-900, Sony) for bright-field intravital microscopy. A 
HD-DVD video recorder (model LRH-890, LG Electronics Inc.) was connected with 
this camera to record video images for playback analysis and the captured images 
were projected onto a TV monitor (model 22LG30-UA, LG Electronics Inc.). A 
monochrome deep-cooled CCD digital camera (Retiga™ SRV, QImaging) was also 
connected to the microscope port for fluorescence intravital microscopy, the images 
from which were directly processed by a computer. A 20 × Olympus objective lens 
was used in the experiments.  
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3. Preparation of cremaster muscle for intravital microscopy 
Male mice were anesthetized with an i.p. injection of a mixture of 10 mg/kg 
xylazine and 200 mg/kg ketamine hydrochloride. The mouse cremaster muscle 
preparation was used to study microvascular permeability changes and leukocyte 
recruitment in the microcirculation and tissue.  
3.1 Mouse jugular vein catheterization 
After anesthesia, the area over the right external jugular vein of the neck 
was shaved with an electric razor. The mouse was placed on its back on a surgical 
plate with the head oriented towards the experimenter. The four limbs of the mouse 
were fixed with tape. A horizontal incision (~1 cm) was made above the jugular vein 
anterior in the shaved area. A small curved forceps was used to create a subcutaneous 
pocket on anterior side of incision. The fat tissue was gently teased away from the 
incision site until the jugular vein was visualized. The jugular vein was isolated by 
placing small curved forceps under the vein. Two pieces (approximately 6 cm each) 
of 4-0 suture were fed under the vein. The anterior suture was tied with forceps to 
occlude vein. The catheter was prepared by attaching a PE-10 tubing to a needle with 
a 1cc syringe filled with 100 U/ml heparin saline solution. A small incision was made 
with needle in the vein between the anterior and posterior sutures making sure not to 
cut through the vessel. Using forceps to hold the catheter, the end was fed into the 
lumen of the vessel. The catheter was fed into the vessel about 2-4 mm, ensuring that 
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blood from the vein could flow freely in and out of the catheter. The catheter was 
fixed by tying off the posterior suture. 
3.2  Preparation of cremaster muscle 
The anesthetized mouse was placed ventral side up on the cremaster muscle 
board. To maintain physiological temperature of the mouse and cremaster muscle 
tissue, the board was connected to a water circulator and circulated with 37C-water. 
The cremaster muscle board was also connected to a peristaltic pump that perfused 
the exposed muscle tissue with 37C-warmed bicarbonate-buffered saline (131.9 
NaCl, 4.7 KCl, 1.2 MgSO4, 20 NaHCO3, in mM, pH 7.4) to keep the exposed muscle 
moist. An incision was made on the scrotal skin using a scissor. The left testicle was 
exposed and the underlying connective tissue was then carefully separated from the 
cremaster muscle. Using a cautery and 4-0 sutures, the cremaster muscle was 
cauterized longitudinally, spread and secured on the glass pedestal of the board. A 
glass coverslip (22×22 mm) was used to cover the muscle, and then the muscle was 
ready for viewing under the microscope.  
A single postcapillary venule, 25–40 m in diameter, was selected, and was 
moved to the middle of the screen. The number of rolling, adherent, and emigrated 
neutrophils was determined during video playback analysis. Rolling neutrophils were 
defined as those cells moving at a velocity less than that of erythrocytes within a 
given vessel. The flux of rolling neutrophil was measured as the number of rolling 
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neutrophils passing by a given point in the venule per minute. Neutrophil rolling 
velocity was measured for the first 20 neutrophils entering the field of view at the 
time of recording and calculated from the time required for a leukocyte to roll along a 
100 m length of venule. A neutrophil was considered to be adherent if it remained 
stationary for at least 30 s, and total neutrophil adhesion was quantified as the number 
of adherent cells within a 100-m length of venule in 5 min. Neutrophil emigration 
was defined as the number of cells in the extravascular space (220×210 m2) adjacent 
to the observed venule. 
4. Induction of neutrophil recruitment in cremaster muscle 
         To induce neutrophil recruitment in cremaster muscle, recombinant mouse 
TNF (0.1 g; R&D Systems, MN, USA) in 100 l of saline was injected 
intrascrotally into C57BL/C, 129/SvJ or Lsp1
/ 
mice 4 h before each experiment. In 
some mice, exposed, untreated cremaster muscles were superfused with control 
superfusion buffer, 5 nM KC or MIP-2 (both from R&D Systems, MN, USA) for 1 h. 
5. Microvascular permeability measurement  
FITC-labeled bovine serum albumin (BSA) at 25 mg/kg (Sigma-Aldrich, 
MO, USA) was injected to the mice i.v. at the start of the experiment, and 
FITC-derived fluorescence (excitation at 495 nm, and emission at 525 nm) was 
detected using a monochrome deep-cooled CCD digital camera. The selected venule 
(25–40 m in diameter) was kept in the middle of the screen and pictures taken at 
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different time points were saved in a computer. Image analysis software, 
METAMORPH (MetaMorph®, Molecular Devices Inc., PA, USA), was used to 
determine the intensity of FITC-albumin–derived fluorescence within the lumen of 
the venule and in the adjacent perivascular tissue. Background was defined as the 
fluorescence intensity before FITC-albumin injection. The index of vascular albumin 
leakage, permeability index, at different time points was determined according to the 
following ratio expressed as a percentage: (mean interstitial intensity - background)/ 
(venular intensity - background). 
6. Depletion of circulating neutrophils in mice 
Mice were injected (i.p.) with 200 g/mouse anti-neutrophil antibodies 
(anti-mouse Ly-6G FG purified RB6-8C5, also called anti-GR-1, eBioscience, CA, 
USA) for 24 h. This treatment depleted circulating neutrophils by >98% [131]. We 
have confirmed the effect of this treatment by examination of peripheral blood cell 
count and differential cell count on a blood smear after 24-h anti-mouse Ly-6G 
treatment. 
7. Statistical analysis 
Data in this thesis represent mean ± SEM. Data were analyzed using 
One-way ANOVA, post hoc comparison or Student’s t test. P<0.05 and P<0.01 were 
considered as statistically significant and very significant, respectively. 
 
34 
 
 
 
Figure 2. An intravital microscope system. An Olympus BX61WI up-right microscope is 
connected with two types of cameras, and the images are projected to a HD-DVD 
recorder and a TV monitor, and to a computer to record the images. A peristaltic pump 
and a 37C-water circulation bath were used to maintain physiologic environment for the 
exposed cremaster muscle and for the anesthetized mouse.   
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Results 
1. The effect of KC and MIP-2 on microvascular permeability changes 
1.1 Both KC and MIP-2 increases neutrophil adhesion and emigration 
MIP-2 and KC are two CXC chemokines that are expressed at the site of 
acute inflammation. These two chemokines have been shown to be involved in 
inducing neutrophil recruitment in microvasculature [132]. In my experiment, KC or 
MIP-2 was superfused on the exposed cremaster muscle to induce neutrophil 
recruitment in local postcapillary venules. Without KC or MIP-2 treatment, there 
were no chemokine-induced adherent and emigrated neutrophils in postcapillary 
venule. The baseline adherent and emigrated leukocytes, were always kept at 0-3 
cells (per 100 m-length venule over 5 min for adhesion and per field of view for 
emigration), a minimal level that is acceptable for intravital microscopy studies. 
After superfusion of KC or MIP-2 on the exposed cremaster muscle for 60 min, the 
adherent and emigrated neutrophils were determined. Figure 3 demonstrated that the 
numbers of adherent neutrophils in the cremasteric venules was significantly 
increased after KC or MIP-2 superfusion. Also a large number of neutrophils were 
found emigrated into the tissue. The induction of adhesion by MIP-2 was slightly 
higher than that by KC, whereas the emigration in response to MIP-2 was a little 
lower compared to KC. These differences are not significant, and the effects of 
MIP-2 and KC on neutrophil recruitment are similar. 
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Figure 3. Effect of superfusion of KC or MIP-2 on neutrophil adhesion and emigration in 
cremasteric postcapillary venules of WT mice. KC or MIP-2 was dissolved in superfusion 
buffer at 5 nM and warmed to 37C before superfusion. The control mice were 
superfused only with 37C superfusion buffer. Data represent mean ± SEM from four 
mice per group. **, P<0.01, KC or MIP-2 compared with the control group. 
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1.2 The effect of KC and MIP-2 on venular permeability changes is similar 
       During 60 min superfusion of KC or MIP-2, the permeability index of 
postcapillary venule was measured at every 5 min. Without any treatment, vascular 
permeability was stable and normal. At 60 min, superfusion of KC or MIP-2 both 
caused a significant increase in microvascular permeability (Figure 4). Comparing 
the two curves representing KC and MIP-2 in Figure 4, we noticed that the increases 
of permeability in response to KC tended to be higher than MIP-2. In response to KC, 
permeability increases of postcapillary venules began to reach significant level at 
early time point of 20 min. The permeability index kept increasing and finally was 
about 30% increased over that in the control group. Under MIP-2 treatment, the 
increases of permeability were not significant until 55 min. The final increase was 
about 15% over that at the starting point and that in the control group. But there was 
no significant difference between the KC and MIP-2 groups (P>0.05). So we 
concluded that both KC and MIP-2 significantly increase microvascular permeability, 
and that the effect of KC and MIP-2 on permeability changes is similar. 
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Figure 4. The increases of microvascular permeability after KC or MIP-2 superfusion in 
cremasteric postcapillary venules in WT mice. The protocol of KC or MIP-2 superfusion 
was described in the legend of Figure 3. Data represent mean ± SEM of the permeability 
index from four mice per group. *, P<0.05, **, P<0.01, KC or MIP-2 compared with the 
control group. 
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2. The effect of TNF on microvascular permeability changes 
        TNF has been known as a proinflammatory cytokine that is produced 
during acute inflammation and activates various inflammatory cells. The local 
intrascrotal injection of TNF induces acute inflammation at the site. After 4 h of 
TNF treatment, I began to measure the permeability index and neutrophil 
recruitment at postcapillary venules in cremaster muscle. Figure 5 shows that the 
increases in permeability reached significant levels at 15 min after 4 h TNF 
treatment. At 60 min, the increase of permeability was about 35% over that in 
untreated control group. Therefore, TNF treatment significantly increases 
permeability of postcapillary venule. Also, the adherent and emigrated neutrophils 
were significantly increased. More than 20 cells adhered to the venule and about 
22-23 cells already migrated through the endothelial cells to the tissue (Figure 6). 
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Figure 5. The increases of microvascular permeability in cremasteric postcapillary 
venules after 4 h TNF treatment in WT mice. The mice were given intrascrotal 
injections of TNF (100 ng/mouse in 100 l sterile saline), and the microvascular 
permeability index was determined by intravital microscopy after 4 h TNF treatment. 
The control mice were injected with saline alone. Data represent mean ± SEM of 
permeability index from three mice per group. *, P<0.05, **, P<0.01, TNF compared 
with the control group. 
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Figure 6. Effect of injection of TNF on neutrophil adhesion and emigration in 
cremasteric postcapillary venules of WT mice after 4 and 5 h of TNF injection. The 
protocol of TNF injection was described in the legend of Figure 5. Data represent mean 
± SEM from three mice per group. **, P<0.01, TNF compared with the control group. 
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3. The role of LSP1 in hyperpermeability changes in microvasculature 
3.1 The role of LSP1 in KC-induced hyperpermeability changes 
To study the role of LSP1 in CXC-chemokine induced permeability 
changes, we used two types of mice 129/SvJ (WT) and Lsp1
/ 
mice in my 
experiments. Because I have shown that chemokine KC and MIP-2 have similar role 
in permeability change and neutrophil recruitment, I only used KC in my following 
experiments. Without any treatment, the deficiency of LSP1 did not affect 
permeability index compared with WT mice (Figure 7). At the resting condition of 
venule, LSP1 had no role in endothelial permeability. When KC was applied to 
cremaster muscle, the permeability index in WT and Lsp1
/ 
mice was significantly 
higher than the control group of each genotype. But there were no statistically 
significant differences in the permeability index between the two genotypes of mice 
after KC superfusion (P>0.05). The increases of permeability in both types of mice 
reached significant levels at 20 min. The increases in permeability lasted until at 
least 60 min. At 60 min, the increases of permeability in response to KC were similar 
between WT mice and Lsp1
/
 mice (Figure 7).   
After 60 min exposure of cremaster muscle to KC, I measured 
neutrophil adhesion and emigration cells in the venules. Figure 8 demonstrates a 
significant inhibition of neutrophil adhesion and emigration in Lsp1
/
 mice 
compared with WT mice in response to KC. LSP1 is important for neutrophil 
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adhesion and emigration in response to KC superfusion. 
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Figure 7. Change of microvascular permeability after KC superfusion in cremasteric 
postcapillary venules in WT and Lsp1
/
 mice. The protocol of KC superfusion was 
described in the legend of Figure 3. Data represent mean ± SEM of permeability index 
from three mice per group. *, P<0.05, KC-superfused group compared with the control 
group. 
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Figure 8. Effect of superfusion of KC on neutrophil adhesion and emigration in 
cremasteric postcapillary venules of WT and Lsp1
/ 
mice. The protocol of KC 
superfusion was described in the legend of Figure 3. Data represent mean ± SEM from 
three mice per group. *, P<0.05, WT mice compared with Lsp1
/
 mice. 
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3.2 The role of LSP1 in TNF-induced vascular hyperpermeability 
changes 
        To study the role of LSP1 in TNF-induced vascular hyperpermeability, 
we have used TNF intrascrotal injection for 4-5 h in Lsp1/ and WT mice. 
Previous results in this thesis demonstrated that TNF caused significant increases in 
vascular permeability. In this part, I studied the role of LSP1 in this vascular 
permeability change induced by TNF. Similar to KC, the increases of permeability 
in both WT and Lsp1
/
 mice in response to TNF were comparable (Figure 9), but 
the deficiency of LSP1 had no effect on adhesion (Figure 10). Both types of mice 
had more than 20 cells adhering to the venule in 5 min at 4 h and 5 h after TNF 
treatment. Very significant inhibition of emigration (~50%) was noted in Lsp1
/
 
mice compared to that in WT mice in response to TNF (Figure 10). This suggested 
that LSP1 is important for neutrophil emigration but does not play a role in 
neutrophil adhesion to postcapillary venules in response to 4-5 h TNF treatment. 
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Figure 9. Change of microvascular permeability after TNF injection in cremasteric 
postcapillary venules in WT and Lsp1
/
 mice. The protocol of TNF injection was 
described in the legend of Figure 5. Data represent mean ± SEM of permeability index 
from three mice per group. *, P<0.05; **, P<0.01, TNF compared with the control 
group. 
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Figure 10. Effect of TNF injection on leukocyte adhesion, and emigration in 
cremasteric post-capillary venules of WT and Lsp1
/
 mice. The protocol of TNF 
injection was described in the legend of Figure 5. Data represent mean ± SEM from 
three mice per group. *, P<0.05, Lsp1
/
 mice compared with WT mice. 
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3.3 Loss of LSP1 impairs neutrophil emigration without changing 
microvascular permeability 
    3.3.1 Adhesion and permeability increases 
           The role of LSP1 in neutrophil adhesion induced by TNF is different 
from that induced by KC. The deficiency of LSP1 had no effect on adhesion in 
response to TNF as measured between 4-5 h after treatment, but reduced the 
adhesion in response to KC as measured across 1 h after treatment. However, under 
both treatment conditions the increases of permeability in Lsp1
/
 mice were still 
comparable with that in WT mice. I calculated the permeability index per adherent 
neutrophil ratio at 60 min to determine the contribution of each adherent cell to the 
permeability increases. In response to KC, each adherent Lsp1
/ 
neutrophil 
contributed much more than each adherent WT neutrophil to the permeability index 
increases (Figure 11). But under TNF stimulation, there was no difference of the 
contribution to permeability increases in each adherent Lsp1
/
 or WT neutrophil 
(Figure 12). This result suggested that LSP1 has a role in KC-induced adhesion of 
neutrophils to the postcapillary venules and has an important impact on KC-induced, 
neutrophil adhesion-related vascular permeability increases. This also suggested that 
LSP1 does not play a role in TNF-induced neutrophil adhesion to the inflamed 
venule and has no impact on TNF-induced, neutrophil adhesion-related venular 
permeability increases. 
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    3.3.2 Emigration and permeability increases 
          After 60 min of KC superfusion and 5 h of TNF treatment, the 
neutrophil emigration in WT mice was significantly higher compared with Lsp1
/
 
mice in response to both KC and TNF (Figure 8 and 10), and also there was no 
difference in permeability increases between two types of mice after the treatment 
(Figure 7 and 9). Comparing the value of permeability index per emigrated 
neutrophil, it is obvious that the contribution of each emigrated Lsp1
/ 
neutrophil 
was significantly higher than each emigrated WT neutrophil (Figure 11 and 12). 
These results confirmed that LSP1 has an important role in the regulation of 
neutrophil emigration induced by either cytokine or chemokine and indicated that 
LSP1 contributes to the integrity of the endothelium during neutrophil emigration; 
deficiency of LSP1 substantially increases the vascular permeability induced by each 
transmigrating neutrophils. 
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Figure 11. Permeability index per adherent and migrating neutrophil in response to KC 
superfusion for 60 min. Data represent mean ± SEM from three mice per group. *, 
P<0.05, WT mice compared with Lsp1
/
 mice. 
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Figure 12. Permeability index per adherent and emigrated neutrophil in response to 
TNF 5 h treatment. Data represent mean ± SEM from three mice per group. *, P<0.05, 
WT mice compared with Lsp1
/
 mice. 
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4. The role of neutrophil-endothelial interactions in microvascular 
permeability changes 
               It was reported that at 24 h after the injection of anti-neutrophil 
antibody anti-Gr-1 into mice, more than 98% neutrophils in the circulation are 
depleted [131]. We have confirmed the effect of this antibody in the depletion of 
circulating neutrophils. After KC or TNF administration in these neutrophil-depleted 
mice, there were almost no rolling neutrophils in the venules. Consequently, the 
number of adherent and emigrating neutrophils was extremely low (Figure 13 and 14). 
This depletion of neutrophils in circulation completely diminished the interactions 
between neutrophils and endothelial cells. The depletion of neutrophils also reduced 
the permeability increases induced by KC to the baseline in both mice strains (Figure 
15). This suggested that the increases of permeability were basically caused by 
neutrophil-endothelial interactions in response to KC in both types of mice. Similar 
results were obtained in response to 4 to 5 h TNF treatment (Figure 16). The 
depletion of neutrophils also significantly inhibited the permeability increases 
induced by TNF. My data indicated that, at 4-5 h after TNF (100 g) local 
treatment, it is the neutrophil-endothelial cell interaction induced by TNF, but not 
the activation of endothelium by TNF treatment that is important in microvascular 
permeability increases in WT and Lsp1
/
 mice.  
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Figure 13. Effect of superfusion of KC on leukocyte rolling flux, adhesion, and 
emigration in cremasteric postcapillary venules of WT and Lsp1
/
 mice after 24 h 
anti-neutrophil antibody i.p. injection. Because the leukocyte rolling flux was close to 
zero at 24 h after anti-Gr-1 treatment, leukocyte rolling velocity could not be determined. 
The protocol of KC superfusion was described in the legend of Figure 3. Data represent 
mean ± SEM of from three mice per group. *, P<0.05, WT with KC compared with 
Lsp1
/
 mice with KC. 
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Figure 14. Effect of TNF injection on leukocyte rolling flux, adhesion, and emigration 
in cremasteric postcapillary venules of WT and Lsp1
/
 mice after 24 h anti-neutrophil 
antibodies i.p. injection. Because the leukocyte rolling flux was close to zero at 24 h after 
anti-Gr-1 treatment, leukocyte rolling velocity could not be determined. The protocol of 
TNF injection was described in the legend of Figure 5. Data represent mean ± SEM of 
from three mice per group. *, P<0.05, WT with TNF compared with Lsp1/ mice with 
TNF. 
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Figure 15. The changes in microvascular permeability after KC superfusion in 
cremasteric postcapillary venules in WT and Lsp1
/
 mice after 24 h anti-neutrophil 
antibody i.p. injection. The protocol of KC superfusion was described in the legend of 
Figure 3. Data represent mean ± SEM of permeability index from three mice per group. *, 
P<0.05, KC compared to KC with anti-Gr-1. 
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Figure 16. The changes in microvascular permeability after TNF injection in 
cremasteric postcapillary venules in WT and Lsp1
/ 
mice after 24 h anti-neutrophil 
antibody i.p. injection. The protocol of TNF injection was described in the legend of 
Figure 5. Data represent mean ± SEM of permeability index from three mice per group. *, 
P<0.05, and **, P<0.01, TNF compared to TNF with anti-Gr-1, respectively. 
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Discussion 
Acute inflammation is characterized by the recruitment of leukocytes and 
vascular hyperpermeability at the postcapillary venules. In the inflamed tissue, 
microvascular permeability increases and fluid and proteins leak out of blood vessel to 
the extravascular interstitial space. These exudates contain complement proteins and 
antibodies which can kill harmful invading microorganisms [1]. Meanwhile, leukocytes 
in blood stream are stimulated and activated, and they emigrate along the chemoattractant 
gradient to the inflamed site. Some studies have shown that leukocyte recruitment and 
permeability increases in microvasculature are two coupled events [119, 120], but some 
other studies have indicated there is a disassociation between permeability changes and 
leukocyte recruitment [129, 130]. Therefore, there is still a controversy. LSP1, a 52kDa 
intracellular Ca
2+
 and F-actin binding protein[91], has been shown to have an important 
role in leukocyte transendothelial migration induced by CXC chemokine KC and 
cytokines TNF and IL-1 and in the permeability increases induced by histamine [106]. 
But the role of LSP1 in permeability changes induced by chemokines and cytokines has 
not been studied. The primary goal in my study in this thesis is to investigate the role of 
LSP1 in neutrophil recruitment and microvascular permeability changes during 
neutrophil-endothelial cell interactions in the neutrophil recruitment process.  
In this study, we found that during neutrophil recruitment, microvascular 
permeability in postcapillary venules was increased, and that after depletion of circulating 
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neutrophils, therefore abolishing neutrophil-endothelial cell interactions, there was no 
microvascular permeability increases. Thus, at dosages of KC and TNF that we tested in 
the induction of neutrophil recruitment, the hyperpermeability in postcapillary venules is 
due to neutrophil-endothelial cell interactions. Interestingly, LSP1 alone does not 
contribute to the hyperpermeability in postcapillary venules and the role of LSP1 in 
hyperpermeability is through neutrophil-endothelial cell interactions. Loss of LSP1 
causes each adherent or transmigrating neutrophil to contribute much more to the 
hyperpermeability during neutrophil recruitment. 
           In this study, depletion of neutrophils by anti-neutrophil antibody anti-GR-1 
in the circulation almost totally diminished the interactions between neutrophils and 
endothelial cells in the inflamed tissues. Without neutrophil-endothelial cell interactions, 
there was no increase in vascular permeability in the postcapillary venules after KC 
superfusion or after 4-5 h TNF treatment. Therefore, the hyperpermeability in 
postcapillary venule induced by KC or TNF was due to neutrophil-endothelial cell 
interactions. How neutrophil-endothelial interactions increase vascular permeability is 
not completely understood, but there may be several possible mechanisms that are 
involved. Firstly, transendothelial migration of neutrophils disrupts junctional molecules 
which are important in maintaining endothelial barrier functions. VE-cadherin, which is 
the major component of AJs, is located in endothelial cell contacts when there is no 
neutrophil trafficking. With neutrophil adherence, VE-cadherin is redistributed and is no 
longer in the intercellular space. The -catenin linking to AJs is also redistributed. This 
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disruption of AJs causes permeability increases [126, 133] . A research group reported 
that activated neutrophils can induce phosphorylation of two major AJ proteins, 
VE-cadherin and -catenin, which is accompanied by the distribution of these two 
proteins [134]. Neutrophil transmigration can also disrupt TJs between endothelial cells. 
During neutrophil transmigration, ZO-1 and occludin disappear from the endothelial 
border, and ZO-2 expression level is significant reduced. Occludin was found to be 
cleaved to a smaller fragment [135]. Some other junctional molecules have also been 
reported to have roles in neutrophil transmigration, such as PECAM-1 and JAMs. 
Therefore, it is reasonable that the disruption in the integrity of endothelial junctions 
causes increases in endothelial permeability. 
          Secondly, the interactions between neutrophils and endothelial cells activate 
endothelial cells to further activate certain signal pathways in the two cell types. Gautam 
et al. reported that cross-linking 2-integrins between neutrophils and endothelial cells 
causes increases in endothelial cell cytosolic calcium concentrations and F-actin content, 
and subsequently leads to permeability increases [136]. Further studies showed that 
activated neutrophils promote endothelial cell MLC phosphorylation which causes 
endothelial cell retraction and permeability increases [137, 138]. The adhesion of 
neutrophils to endothelial cells causes an elevation of the cytosolic free calcium 
concentrations in endothelial cells which is required for subsequent neutrophil 
transendothelial migration and is important for the increases in endothelial permeability 
[123, 124]. 
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         Finally, activated neutrophils release various compounds which may induce 
vascular permeability increases. Activated neutrophils have been reported to be a source 
of ROS and the production of ROS is important for vascular permeability increases [139] . 
The production of ROS triggers the internalization of VE-cadherin in endothelial 
junctions and increases endothelial permeability [140]. Heparin-binding protein (HBP), a 
member of the neutrophil cationic proteins, was reported to increase endothelial 
permeability. The secretion of HBP can be triggered by cross-linking of 2 integrin, and 
this secretion induces the rearrangement of the endothelial cell cytoskeleton. HBP acts as 
a mediator for neutrophil adhesion-induced permeability increases [141]. It is also 
reported that activated neutrophils produce leukotrienes and prostaglandins, which 
increase endothelial permeability [51, 142]. 
          By using Lsp1
/
 mice in this study, we reported that loss of LSP1 causes 
each adherent or transmigrating neutrophil to contribute more to the hyperpermeability 
during recruitment. After depletion of neutrophils in the circulation of WT or Lsp1
/
 
mice, LSP1 had no role in permeability changes, suggesting that the role of LSP1 in the 
hyperpermeability in postcapillary venules is through the neutrophil-endothelial cell 
interactions. It is well known that endothelial cells play an active role in neutrophil 
transmigration. During neutrophil-endothelial cell interactions, endothelial ICAM-1 
relocalizes and is enriched in endothelial borders, forming a cup-like structure that 
surrounds the site of transmigration [26, 27]. This cup-like structure in vitro was 
described as the dome-like structure formation of endothelial cells in vivo [143]. It was 
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reported in a recent study that LSP1 is expressed in mouse and human endothelial cells 
and that endothelial LSP1 is important in neutrophil emigration induced by the CXC 
chemokine KC and the cytokine TNF [106]. Petri and his colleagues reported very 
recently that after stimulation with TNF, endothelial LSP1 association with the 
cytoskeleton region was significantly increased [112]. In WT mice, endothelial cells 
formed domes completely covering the transmigrating neutrophil. But in Lsp1
/
 mice, 
endothelial cells could not form complete domes, and only covered the transmigrating 
neutrophil pseudopodia. A lack of LSP1 decreases the motility of endothelial cells during 
neutrophil transmigration [112]. The impaired motility of endothelial cells decreased the 
number of neutrophils crossing the endothelium, whereas incomplete dome formation in 
Lsp1
/
 mice disrupted the integrity of the postcapillary venules leading to increased 
vascular permeability. In a previous study, LSP1 had been reported to have an important 
role in the hyperpermeability in postcapillary venules at 60 min treatment of histamine 
which did not induce neutrophil emigration [106]. LSP1 could directly affect 
hyperpermeability without involving neutrophil-endothelial cell interactions. Therefore, 
LSP1 may have different roles in vascular permeability increases under various 
inflammatory conditions.  
         As we demonstrated in this study, LSP1 has a role in hyperpermeability 
elicited by KC-induced neutrophil adhesion and emigration, and by TNF-induced 
neutrophil emigration, but does not appear to be involved in the hyperpermeability in 
TNF-stimulated neutrophil adhesion. This suggests the possibility that TNF stimulates 
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an LSP1-independent signaling mechanism that is important for neutrophil 
adhesion-related regulation of microvascular permeability increases. A research group 
found that TNF-induced neutrophil adhesion could be inhibited by Src, epidermal 
growth factor receptor (EGFR), and PI3K/Akt inhibitors, suggesting that TNF induces 
neutrophil adhesion through Src, EGFR, and PI3K/Akt [144]. The mechanisms of 
TNF-induced neutrophil adhesion are still under investigation. 
        In this study, I demonstrated that in response to KC or TNF, the 
hyperpermeability in postcapillary venules is due to neutrophil-endothelial cell 
interactions, but mechanisms of neutrophil-induced hyperpermeability remain 
incompletely understood. Therefore, I raised some possibilities in this discussion on the 
possible mechanisms. My study demonstrated that LSP1 contributes to the integrity of 
the postcapillary venule through interactions between neutrophils and endothelial cells 
during neutrophil recruitment. The role of LSP1 in the hyperpermeability in postcapillary 
venules is still under investigation because it appears that LSP1 has different roles in 
hyperpermeability under various stimuli. Also, the mechanisms of TNF-induced 
neutrophil adhesion require more studies. In this study, we only tested the effect of 4-5 h 
TNF treatment on permeability increases and neutrophil recruitment. These time points 
are most commonly used for the study of mechanisms of inflammation and neutrophil 
recruitment when TNF is applied. It could be better to examine the effect of TNF 
treatment at different time points to gather more information on the role of LSP1 and the 
effect of neutrophil-endothelial cell interactions in mcirovascular permeability changes 
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during neutrophil recruitment. In future work, more advanced microscopy technologies 
such as spinning-disk confocal intravital microscopy and two-photon microscopy may be 
used to directly visualize and determine the whole process of neutrophil transendothelial 
migration and the increases of endothelial permeability in greater details.  
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